Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the…

By M. Bertrand, H. Rupprecht, P. Urban, A. Gershlick. Circulation, 2000

1,068 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study* (2005, neutral): “Chronic total occlusions ( 3 months) 8 (6) 10 (8) 0.”
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. (2002, background): “Clopidogrel may also be recommended for immediate and long-term therapy in patients who do not tolerate aspirin (CAPRIE)([154]), and is recommended in patients receiving a stent([155]) (level of evidence: B).”
Polymorphism of human cytochrome P450 enzymes and its clinical impact (2009, background): “Clopidogrel reduces the risk of thrombotic events in patients with a history of artherosclerotic diseases, such as stroke or myocardial infarction (Bertrand et al., 2000; Fukuuchi et al., 2008; Jarvis and Simpson, 2000).”